← Back to Search

MRI Monitoring for Prostate Cancer (NA_00067284 Trial)

N/A

Recruiting

Led By Danny Song, M.D.

Research Sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Histologically-confirmed prostate cancer

Plan to undergo external radiation treatment of prostate cancer

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 2 months

Awards & highlights

NA_00067284 Trial Summary

This trial is testing whether using MRI to monitor tissue response during and after radiotherapy for prostate cancer is feasible, and if so, whether it can provide more information than simple anatomic information.

Who is the study for?

This trial is for men with confirmed prostate cancer who are planning to receive external radiation treatment. It's not suitable for those with a cardiac pacemaker, metal implants, chronic kidney disease, an inability to undergo MRI scans, or allergies to gadolinium-based contrast agents.Check my eligibility

What is being tested?

The study is testing the use of advanced MRI techniques like MRS, DWI, and DCE during and after radiotherapy to monitor tissue response in prostate cancer patients. The goal is to see if these MRIs can provide early information on tumor recurrence and normal tissue damage.See study design

What are the potential side effects?

There are generally no side effects associated directly with undergoing MRI imaging itself; however, there may be risks related to lying still for long periods during the scan or reactions in those allergic to contrast agents used.

NA_00067284 Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

My prostate cancer diagnosis was confirmed through a tissue examination.

Select...

I am planning to receive external radiation for prostate cancer.

NA_00067284 Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 2 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~2 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

MRI use to predict treatment response

Secondary outcome measures

Evaluating MRI use to predict functional radiation treatment dose distribution

NA_00067284 Trial Design

1Treatment groups

Experimental Treatment

Group I: MRI imagingExperimental Treatment1 Intervention

Use of MRI imaging in conjunction with standard radiation treatment

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsLead Sponsor

558 Previous Clinical Trials

32,900 Total Patients Enrolled

56 Trials studying Prostate Cancer

3,328 Patients Enrolled for Prostate Cancer

Danny Song, M.D.Principal InvestigatorThe Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

3 Previous Clinical Trials

56 Total Patients Enrolled

2 Trials studying Prostate Cancer

50 Patients Enrolled for Prostate Cancer

Media Library

MRI imaging Clinical Trial Eligibility Overview. Trial Name: NCT01607008 — N/A

Prostate Cancer Research Study Groups: MRI imaging

Prostate Cancer Clinical Trial 2023: MRI imaging Highlights & Side Effects. Trial Name: NCT01607008 — N/A

MRI imaging 2023 Treatment Timeline for Medical Study. Trial Name: NCT01607008 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Can members of the public participate in this experiment?

"Clinicaltrials.gov confirms that this medical trial is actively seeking participants and has been accepting applications since November 16th 2012, with the most recent edits being made on October 12th 2022."

Answered by AI

What is the scale of enrollment for this experiment?

"Correct. Data hosted on clinicaltrials.gov indicates that this medical study, which was initially published on November 16th 2012, is currently recruiting participants. Approximately 20 patients need to be recruited from 1 particular medical centre."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

MRI for Assessing Prostate Cancer Response

2012. "MRI for Assessing Prostate Cancer Response". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT01607008.

All > Prostate Cancer Baltimore > Paid Studies Maryland